Finance Watch: Biopharma IPO Queue Grows As Market Conditions Improve
Verrica, IGM Reveal Restructuring Plans
Public Company Edition: Septerna, Apimeds, CAMP4 and Upstream filed paperwork with the SEC aiming to take advantage of renewed investor interest in IPOs. Also, Biohaven closed a $287.5m offering and Grifols subsidiary GigaGen obtained up to $135m from BARDA.
